MedTrace Logo

BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

NCT04830228 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2023-12-12

No results posted yet for this study

Summary

BIOTRONIK cobalt chromium balloon-expandable Dynetic-35 stent in association with Passeo-35 Xeo peripheral dilation catheter for the treatment of peripheral iliac lesions

Conditions

Interventions

DEVICE

Ballon expandable stent and PTA

Endovascular treatment for the peripheral artery disease of the Iliac artery

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Marianne Brodmann, Prof. Dr. · Substitute Head of the Clinical Division of Angiology, Department of Internal Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-10
Primary Completion
2023-02-28
Completion
2028-02-28

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Hungary
  • Latvia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04830228 on ClinicalTrials.gov